Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP & General Mgr, Industrial
-
Stock Symbol
-
REGN on Nasdaq
Daniel P. Van Plew - trading volume in the past year for Regeneron Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
34.8K |
$25.4M |
$730.81 |
Dec 16, 2024 |
Direct |
|
|
Common Stock |
1.1K |
$804K |
$730.81 |
Dec 16, 2024 |
By 401(k) Plan |
|
|
Non-Qualified Stock Option (right to buy) |
13.5K |
|
|
Dec 6, 2024 |
Direct |
Common Stock |
|
Non-Qualified Stock Option (right to buy) |
0 |
|
|
Feb 9, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.